Stocks股票 / Health Care / REGN

Regeneron Pharmaceuticals · Health Care

REGN US listed · USD美股 · 美元

Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York.Regeneron Pharmaceuticals, Inc. 是一家美国生物技术公司,总部位于纽约州威斯特彻斯特县。

Large cap大盘 · $83B Health Care Rate-sensitive利率敏感
$805.02
Regular quote常规时段报价
-$14.07 · -1.72%
Extended quote unavailable. Showing the regular quote.盘前盘后报价暂不可用,现显示常规时段报价。
52w low52周低 $570high高 $859
Constructive — building a base建设性 — 正在筑底 Trend intact — hold; add on dips toward the 10-day average.趋势完好——持有;可在回调至 10 日均线附近时加仓。 As of 2026-10-26截至 2026-10-26

Company news公司新闻

The latest reporting最新报道

One story, with the reporting behind it.将同一事件汇总,保留各来源报道。

Open in Terminal在终端打开
Checking access…正在检查访问权限…
Company intelligence公司情报

The latest call, in context把最新财报放回历史脉络

A synthesized event record across management commentary and recorded metrics. Read as context; verify exact wording in the transcript before relying.综合管理层表述与记录指标形成事件档案。仅供参考;使用前请在电话会原文中核对准确措辞。

Checking latest record正在检查最新记录

Live company record实时公司记录

JavaScript loads the source-bounded event record here. Open Terminal if the live module does not start.JavaScript 会在此加载受来源约束的事件记录。如实时模块未启动,请打开终端。

Continue with full transcript history继续查看完整电话会历史 ↗

Price chart价格图表

daily · interactive日线 · 可交互 Open in Terminal打开终端 ↗
Loading chart…图表加载中…
The interactive chart could not load here.互动图表暂时无法在此加载。 Open the live chart in Terminal在终端中打开实时图表 ↗
Candles, volume and moving averages — pan and zoom inside the chart.蜡烛图、成交量与均线 — 图内可缩放拖动。 MMastermind Terminal — live & interactiveMastermind 终端 — 实时互动 ↗

Technicals技术面

daily bars日线数据 · 2026-10-26
Trend Ribbon — Uptrend State
Momentum (RSI 14)动量(RSI 14) 58
Neutral zone中性区域
vs 50-day average相对50日均线 +1.7% above上方 Uptrend intact趋势完好
vs 200-day average相对200日均线 +9.6% above上方 Long trend up长期向上
Trend strength (ADX)趋势强度(ADX) 21 Trending趋势中
Volatility波动率 65th percentile第65百分位
These readings feed the stance at the top — one source per number, refreshed nightly.以上读数构成页首的引擎立场 — 每个数字只有一个来源,每晚更新。

Earnings财务业绩

next report下次财报 2026-10-30
5
days to go天后公布

Estimates being cut预期下调

Beat expectations 4 quarters in a row连续 4 季度超预期

Post-earnings drift: +2.8% (20d)财报后漂移:+2.8%(20日)

+56.6% Jun 2026
+19.4% Mar 2026
+12.3% Dec 2025
+28.1% Sep 2025

EPS surprise vs consensus, last quarters每股收益相对预期的超预期幅度(近几个季度) · average平均 29.1%

Valuation估值

Looks cheap vs sector相对行业偏便宜
Multiple指标REGN Sector median行业中位Cheaper than相对便宜
P/E (trailing)市盈率(历史) 18.40x 31.50 81%
P/B市净率 2.65x 3.57 66%
P/S市销率 5.78x 3.19 28%
Earnings yield盈利收益率 5.44% 2.37 86%
FCF yield自由现金流收益率 4.92% 3.88 68%
Shareholder yield股东收益率 4.15% 1.83 80%
EV/EBITDA企业价值/EBITDA 19.83x 19.32 46%
P/FCF市值/自由现金流 20.31x 23.56 63%
"Cheaper than" = share of sector peers trading richer on that multiple.「相对便宜」= 行业中该指标估值更高的同行占比。

Financials财务数据

fiscal years财年
Revenue营业收入 $14.3B2025
20202025
5-yr growth5年复合增速 11.0%
Earnings per share每股收益 $41.482025
20202025
5-yr growth5年复合增速 6.3%
Free cash flow自由现金流 $4.1B2025
20202025
Operating margin营业利润率
24.9%
Net margin净利率
31.4%
FCF margin自由现金流利润率
34.7%
Balance-sheet quality财务体质 4/7 Bankruptcy risk: safe zone破产风险:安全区 Return on equity股本回报率 14% Clean稳健

Leverage杠杆

Net debt / EBITDA净债务/EBITDA-0.27
Current ratio流动比率4.13

Capital allocation资本配置

Buybacks (TTM)回购(TTM)$3.4B
Stock-based comp股权薪酬$993.7M

Debt coming due到期债务

SEC filingsSEC 文件

Its filings are available, but they do not break debt down by the year it comes due — every bucket below is unreported.已获取该公司的 SEC 文件,但文件中未按到期年度拆分债务 —— 以下各区间均未披露。

Next 12 months未来12个月 not reported未披露
Year 2第2年 not reported未披露
Year 3第3年 not reported未披露
Year 4第4年 not reported未披露
Year 5第5年 not reported未披露
After year 55年以后 not reported未披露

Not every company reports a year-by-year schedule. Nothing is being estimated in its place.并非所有公司都会披露逐年到期安排;此处不作任何估算替代。

A cash-flow scenario is unavailable until the filing inputs are verified.报告数据核实前,现金流情景暂不可用。

Capital-need coverage is not available for this issuer yet.该发行人的资本需求覆盖信息暂不可用。

Reported facts remain separate from the cash-flow scenario until identity and filing provenance are confirmed.在确认身份与报告来源之前,已披露事实与现金流情景保持分离。

Research context only — reported figures from SEC filings, not a rating, a signal or investment advice.仅供研究参考 — 数据摘自 SEC 文件披露口径,不构成评级、信号或投资建议。

Why is it moving为何波动

6 checks · nightly六项检查 · 每晚
Sector / Theme行业/主题 Health Care (Equal-Weight) theme — #4 of 49 themes「医疗保健(等权)」主题 — 49 个主题中第 4 位
Macro宏观 Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓 Short interest changed -14.9%空头仓位变动 -14.9%
Technical技术面 REGN took relative-strength leadershipREGN 取得相对强弱领先

Options positioning期权持仓

as of last close截至上一收盘

Market makers are net long gamma — price pinned near current level做市商净持有正伽玛,价格倾向于在当前水平附近震荡

Expected daily move预期日波动
±2.39%
Expected weekly move预期周波动
±5.35%
Gamma flip伽玛翻转位
$679
25d risk reversal25d风险逆转
0.8%
Skew: balanced偏斜:balanced
Call and put walls are plotted on the Trade levels ladder →看涨/看跌期权墙已标注在「交易点位」阶梯上 →

Ownership & smart money持仓与聪明钱

13F

Insider activity:内部人动向: -$3.5M net (0 buyers, 4 sellers)-$3.5M 净值(0 买家,4 卖家)

Signal history信号历史

engine events引擎事件
BOTTOMING → UPTREND筑底中 → 上涨趋势 HOLD. Day 14 of the cycle, trend intact above a rising 10-day average, weekly still mixed持有。周期第 14 天,趋势完好并位于向上的 10 日均线之上,周线仍为混合
Oct 22, 2026
REGN took relative-strength leadershipREGN 取得相对强弱领先
Relative strength vs SPY crossed above the 90th percentile of the last 90 days — leadership tends to persist. $819.09.相对标普500的强弱上穿近90日的第90百分位 — 领先往往延续。$819.09。
Oct 14, 2026
UNCONFIRMED TURN → BOTTOMING未确认转向 → 筑底中
BUY SETUP买入预备
Oct 14, 2026
REGN daily MACD crossed upREGN 日线MACD上穿
The daily MACD histogram turned positive — fast and noisy, context rather than a standalone trigger. $778.36.日线MACD柱状图转正 — 快速且嘈杂,仅作背景。$778.36。
Oct 8, 2026
REGN StochRSI turned up from oversoldREGN StochRSI自超卖区上行
StochRSI popped back above 20 — the earliest oscillator heads-up that downside momentum is easing. $739.57.StochRSI重回20上方 — 下行动量趋缓的最早预警。$739.57。
Oct 6, 2026
NEARING A LOW → BOTTOMING接近低点 → 筑底中
BUY SETUP买入预备
Oct 6, 2026
REGN reclaimed its 200-day averageREGN 收复200日均线
Price closed back above the 200-day moving average — the classic bull dividing line. $738.72.收盘重回200日均线 — 经典的多头分界线。$738.72。
Oct 5, 2026
REGN lost its 200-day averageREGN 跌破200日均线
Price closed below the 200-day moving average — the classic bear dividing line. $726.47.收盘跌破200日均线 — 经典的空头分界线。$726.47。
Oct 5, 2026
REGN printed a daily-cycle lowREGN 打出日线周期低点
A confirmed local low — in this cycle framework the highest-odds long-entry window. $726.47.一个已确认的局部低点 — 在本周期框架中做多胜率最高的入场窗口。$726.47。
Oct 1, 2026
BOTTOMING → NEARING A LOW筑底中 → 接近低点
GET READY准备
Sep 30, 2026
NEARING A LOW → BOTTOMING接近低点 → 筑底中
BUY SETUP买入预备
Showing the last 15 of显示最近15条,共 2985 signals条信号

Company profile公司档案

Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York.Regeneron Pharmaceuticals, Inc. 是一家美国生物技术公司,总部位于纽约州威斯特彻斯特县。

Style DNA — how it trades vs the market风格基因 — 相对市场的交易特征
Value价值
Below market低于市场
Quality质量
Above market高于市场
Investment资本投入
Below market低于市场
Shareholder payout股东回报
Below market低于市场
Low volatility低波动
Below market低于市场
Low market beta低市场敏感度
Below market低于市场
Earnings quality盈利质量
Above market高于市场
Short interest空头兴趣
Below market低于市场
Watch items — what could change the story关注项 — 可能改变故事的因素
  • Capital intensity rising

The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。

Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。

Browse all stocks浏览所有股票 Open Terminal打开终端

Research context only — not investment advice. Past patterns do not guarantee future results.仅供研究参考,不构成投资建议。历史规律不代表未来表现。

Data through数据截至 2026-10-26 · regenerated nightly每晚更新 · Generated生成于 2026-10-26 05:47 UTC · All coverage所有股票 · Analyzer分析器